Search | IOVS | ARVO Journals

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Real world registry data on contact lens wear in patients with dry eye disease

Ngozi Charity Chidi-Egboka; Himal Kandel; Fiona Stapleton; Laura Elizabeth Downie; Gerd Geerling; Francisco Arnalich-Montiel; David Mingo; Saaeha Rauz; Alberto Recchioni; Jennifer P Craig; Vincent Daien; Fanny Babeau; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2924.

ARVO Annual Meeting Abstract June 2023

Effect of systemic factors on clinical response to endothelial growth factor therapy for diabetic macula edema: a real-life experience

Eloi Debourdeau; robin medard; vuong nguyen; Pierre-Henry GABRIELLE; Catherine Creuzot Garcher; Sandrine Allieu; Mark Gillies; Daniel Barthelmes; Vincent Daien

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2705.

ARVO Annual Meeting Abstract June 2023

Impact of dry eye disease on quality of life: a Save Sight Dry eye Registry study

Himal Kandel; Fiona Stapleton; Laura Elizabeth Downie; David Mingo Botin; Francisco Arnalich; Saaeha Rauz; Vincent Daien; Fanny Babeau; Gerd Geerling; Jennifer P Craig; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3979.

ARVO Annual Meeting Abstract June 2022

The Save Sight Dry Eye Registry: One year capture of real-world data for dry eye

Stephanie L Watson; Maria Paulina Cabrera Aguas; Laura Elizabeth Downie; Fiona Stapleton; David Mingo Botin; Francisco Arnalich; Saaeha Rauz; Vincent Daien; Fanny Babeau; Jennifer P Craig; Gerd Geerling

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1520 – A0245.

ARVO Annual Meeting Abstract July 2019

Trends in eye care use in adults treated for diabetes between 2008 and 2017 in France: a nationwide study

Audrey Cougnard-Gregoire; Jean-Francois Korobelnik; Marie-Noelle Delyfer; Vincent Rigalleau; Vincent Daien; Catherine Creuzot-Garcher; Cecile DelCourt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1074.

ARVO Annual Meeting Abstract July 2019

Antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis

Florian BAUDIN; Eric Benzenine; Anne-Sophie Mariet; Alain M Bron; Vincent Daien; Jean-Francois Korobelnik; Catherine Quantin; Catherine Creuzot-Garcher

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2026.

ARVO Annual Meeting Abstract July 2019

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

Jean-Francois Korobelnik; Laurent Kodjikian; Vincent Daien; Celine Faure; Ramin Tadayoni; Audrey Giocanti-Aurégan; Pascale Massin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3651.

Clinical and Epidemiologic Research June 2019

Subfoveal Choroidal Thickness, Cardiovascular History, and Risk Factors in the Elderly: The Montrachet Study

PDF

Louis Arnould; Alassane Seydou; Pierre-Henry Gabrielle; Charles Guenancia; Christophe Tzourio; Abderrahmane Bourredjem; Youssef El Alami; Vincent Daien; Christine Binquet; Alain Marie Bron; Catherine Creuzot-Garcher
TAGS: medical history, older adult, risk factors, heart disease risk factors
Invest. Ophthalmol. Vis. Sci.. 2019; 60(7):2431-2437. https://doi.org/10.1167/iovs.18-26488

ARVO Annual Meeting Abstract July 2018

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

Rohan W. Essex; Vuong Nguyen; Vincent Daien; Sarah Steinmann; Richard Walton; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1463.

ARVO Annual Meeting Abstract July 2018

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Vuong Nguyen; Kelvin Teo; Judy Simpson; Vincent Daien; Daniel Barthelmes; Mark C Gillies; Richard Walton

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):829.

ARVO Annual Meeting Abstract June 2017

RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY

Daniel Barthelmes; Anagha Vaze; Vuong Nguyen; Vincent Daien; Jennifer J Arnold; Stephanie H Young; Nigel Morlet; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):888.

ARVO Annual Meeting Abstract June 2017

Twelve-month outcomes of ranibizumab versus aflibercept for neovascular age-related macular degeneration: an observational study.

Mark C Gillies; Vincent Daien; Vuong Nguyen; Jennifer J Arnold; Nigel Morlet; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):896.

ARVO Annual Meeting Abstract June 2017

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Vincent Daien; Catherine P Creuzot Garcher; Marie-Noëlle Delyfer; Alain M Bron; Mark C Gillies; Sandy Lacombe; Laurence Papinaud; Dominique Cholley; Caroline Domerg; Audrey Cougnard-Gregoire; Catherine Quantin; Max Villain; Jean Pierre Daures; Cecile DelCourt; Jean-Francois Korobelnik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):902.

ARVO Annual Meeting Abstract June 2017

Social and clinical characteristics associated with low visual acuity at presentation of AMD

Vuong Nguyen; Vincent Daien; Robyn Guymer; Ian McAllister; Nigel Morlet; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1524.

Clinical and Epidemiologic Research April 2017

Visual Impairment, Undercorrected Refractive Errors, and Activity Limitations in Older Adults: Findings From the Three-City Alienor Study

PDF

Virginie Naël; Karine Pérès; Isabelle Carrière; Vincent Daien; Anne-Catherine Scherlen; Angelo Arleo; Jean-Francois Korobelnik; Cécile Delcourt; Catherine Helmer
TAGS: older adult, refractive errors, visual impairment, visual acuity, social participation, instrumental activities of daily living, mobility, activities of daily living
Invest. Ophthalmol. Vis. Sci.. 2017; 58(4):2359-2365. https://doi.org/10.1167/iovs.17-21525

ARVO Annual Meeting Abstract September 2016

Evisceration with autogenous scleral graft and implantation by posterior way with ceramic implants: a seventeen-year study of 134 case reports.

Jeremy NADAL; Vincent Daien; Jacques jerome; Frederic MURA; Didier HOA; Max Villain

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):704.

ARVO Annual Meeting Abstract September 2016

Biometric factors associated with effective lens position in capsular bag after cataract surgery

Julien PLAT; Arnaud Payerols; Max Villain; Didier Hoa; Vincent Daien

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):923.

ARVO Annual Meeting Abstract September 2016

Screening of WFS1 in autosomal recessive and dominant optic atrophies: mutation findings in non-syndromic optic atrophy and assessment of clinical severity

Joanna Grenier; Vincent Daien; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5062.

ARVO Annual Meeting Abstract September 2016

Analyse by adaptative optics of peri foveolar photoreceptors’ density during screening of Hydroxychloroquine induce maculopathy

Fanny Babeau; Timothé Busetto; Max Villain; Vincent Daien

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5102.

ARVO Annual Meeting Abstract September 2016

Impact and safety of cefuroxime for post-operative endophthalmitis after cataract surgery: a national population study

Vincent Daien; Laurence PAPINAUD; Mark C Gillies; Caroline DOMERG; Nicolas NAGOT; Sandy LACOMBE; Jean Pierre DAURES; Isabelle CARRIERE; Max Villain

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1990.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real world registry data on contact lens wear in patients with dry eye disease

Effect of systemic factors on clinical response to endothelial growth factor therapy for diabetic macula edema: a real-life experience

Impact of dry eye disease on quality of life: a Save Sight Dry eye Registry study

The Save Sight Dry Eye Registry: One year capture of real-world data for dry eye

Trends in eye care use in adults treated for diabetes between 2008 and 2017 in France: a nationwide study

Antibiotic prophylaxis and intravitreal injections: impact on the incidence of acute endophthalmitis

Real-World Use of Intravitreal Aflibercept Injections in Diabetic Macular Edema: 1-Year Interim Results of APOLLON.

Subfoveal Choroidal Thickness, Cardiovascular History, and Risk Factors in the Elderly: The Montrachet Study

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY

Twelve-month outcomes of ranibizumab versus aflibercept for neovascular age-related macular degeneration: an observational study.

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Social and clinical characteristics associated with low visual acuity at presentation of AMD

Visual Impairment, Undercorrected Refractive Errors, and Activity Limitations in Older Adults: Findings From the Three-City Alienor Study

Evisceration with autogenous scleral graft and implantation by posterior way with ceramic implants: a seventeen-year study of 134 case reports.

Biometric factors associated with effective lens position in capsular bag after cataract surgery

Screening of WFS1 in autosomal recessive and dominant optic atrophies: mutation findings in non-syndromic optic atrophy and assessment of clinical severity

Analyse by adaptative optics of peri foveolar photoreceptors’ density during screening of Hydroxychloroquine induce maculopathy

Impact and safety of cefuroxime for post-operative endophthalmitis after cataract surgery: a national population study

To View More...

You must be signed into an individual account to use this feature.